Biotech · Private company
Direct Biologics, LLC
Track this companyFree. Adds Direct Biologics, LLC to your Dealase workspace and tells you when its record changes.
Clinical trials83 recruiting or active
Pipeline programs8From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline8
- ExoFloPhase 3 · Acute Respiratory Distress SyndromeClinicalTrials.gov · fetched Nov 12, 2026
- DB-3QPhase 2 · Crohn Disease (CD)ClinicalTrials.gov · fetched Nov 12, 2026
- DB-3QPhase 2 · Perianal Fistula Due to Crohn's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ExoFloPhase 2 · Perianal FistulaClinicalTrials.gov · fetched Nov 12, 2026
- ExoFloPhase 2 · COVID-19ClinicalTrials.gov · fetched Nov 12, 2026
- ExoFloPhase 1 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- ExoFloPhase 1 · Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- ExoFloSolid Organ Transplant RejectionClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials8
- DB-3Q for the Treatment of Medically Refractory Crohn's DiseasePHASE2 · RECRUITING · started Jun 1, 2026ClinicalTrials.gov NCT07625293 · fetched Nov 12, 2026
- DB-3Q bmMSC-EVs in Patients With Perianal Fistulizing Crohn's DiseasePHASE2 · RECRUITING · started May 19, 2025ClinicalTrials.gov NCT06918808 · fetched Nov 12, 2026
- Study of ExoFlo for the Treatment of Perianal FistulasPHASE1_PHASE2 · TERMINATED · started Aug 28, 2023ClinicalTrials.gov NCT05836883 · fetched Nov 12, 2026
- Study of ExoFlo for the Treatment of Medically Refractory Crohn's DiseasePHASE1 · TERMINATED · started Jan 23, 2023ClinicalTrials.gov NCT05130983 · fetched Nov 12, 2026
- Study of ExoFlo for the Treatment of Medically Refractory Ulcerative ColitisPHASE1 · TERMINATED · started Dec 19, 2022ClinicalTrials.gov NCT05176366 · fetched Nov 12, 2026
- Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)PHASE3 · RECRUITING · started Jul 1, 2022ClinicalTrials.gov NCT05354141 · fetched Nov 12, 2026
- Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDSPHASE2 · COMPLETED · started Sep 24, 2020ClinicalTrials.gov NCT04493242 · fetched Nov 12, 2026
- Expanded Access for Use of ExoFlo in Abdominal Solid Organ Transplant PatientsNO_LONGER_AVAILABLEClinicalTrials.gov NCT05215288 · fetched Nov 12, 2026